Cargando…

Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent

Detalles Bibliográficos
Autores principales: Szucs, Zoltan, Joseph, James, Larkin, Tim J., Xie, Bangwen, Bohndiek, Sarah E., Brindle, Kevin M., Neves, André A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958420/
https://www.ncbi.nlm.nih.gov/pubmed/33722249
http://dx.doi.org/10.1186/s13058-021-01414-x
_version_ 1783664817983193088
author Szucs, Zoltan
Joseph, James
Larkin, Tim J.
Xie, Bangwen
Bohndiek, Sarah E.
Brindle, Kevin M.
Neves, André A.
author_facet Szucs, Zoltan
Joseph, James
Larkin, Tim J.
Xie, Bangwen
Bohndiek, Sarah E.
Brindle, Kevin M.
Neves, André A.
author_sort Szucs, Zoltan
collection PubMed
description
format Online
Article
Text
id pubmed-7958420
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79584202021-03-16 Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent Szucs, Zoltan Joseph, James Larkin, Tim J. Xie, Bangwen Bohndiek, Sarah E. Brindle, Kevin M. Neves, André A. Breast Cancer Res Correction BioMed Central 2021-03-15 2021 /pmc/articles/PMC7958420/ /pubmed/33722249 http://dx.doi.org/10.1186/s13058-021-01414-x Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Szucs, Zoltan
Joseph, James
Larkin, Tim J.
Xie, Bangwen
Bohndiek, Sarah E.
Brindle, Kevin M.
Neves, André A.
Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent
title Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent
title_full Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent
title_fullStr Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent
title_full_unstemmed Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent
title_short Correction to: Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent
title_sort correction to: multi-modal imaging of high-risk ductal carcinoma in situ of the breast using c2am: a targeted cell death imaging agent
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958420/
https://www.ncbi.nlm.nih.gov/pubmed/33722249
http://dx.doi.org/10.1186/s13058-021-01414-x
work_keys_str_mv AT szucszoltan correctiontomultimodalimagingofhighriskductalcarcinomainsituofthebreastusingc2amatargetedcelldeathimagingagent
AT josephjames correctiontomultimodalimagingofhighriskductalcarcinomainsituofthebreastusingc2amatargetedcelldeathimagingagent
AT larkintimj correctiontomultimodalimagingofhighriskductalcarcinomainsituofthebreastusingc2amatargetedcelldeathimagingagent
AT xiebangwen correctiontomultimodalimagingofhighriskductalcarcinomainsituofthebreastusingc2amatargetedcelldeathimagingagent
AT bohndieksarahe correctiontomultimodalimagingofhighriskductalcarcinomainsituofthebreastusingc2amatargetedcelldeathimagingagent
AT brindlekevinm correctiontomultimodalimagingofhighriskductalcarcinomainsituofthebreastusingc2amatargetedcelldeathimagingagent
AT nevesandrea correctiontomultimodalimagingofhighriskductalcarcinomainsituofthebreastusingc2amatargetedcelldeathimagingagent